LAUREN THOMAS: Open Payments
NPI 1811152556 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 39 payments from 7 companies in 2025. Trend: 2023 $978 · 2024 $862 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 29 | $447 |
| Madrigal Pharmaceuticals | 5 | $155 |
| Mirum Pharmaceuticals, Inc. | 1 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
Products named: REZDIFFRA, Livmarli, IQIRVO, ENTYVIO, FREESTYLE LIBRE 3, Wegovy.
Industry payments across TX — which companies pay providers there.
